nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—CYP1A2—Dacarbazine—pancreatic cancer	0.0586	0.327	CbGbCtD
Pentoxifylline—CYP1A2—Tamoxifen—pancreatic cancer	0.0466	0.26	CbGbCtD
Pentoxifylline—CYP1A2—Erlotinib—pancreatic cancer	0.0396	0.221	CbGbCtD
Pentoxifylline—CYP1A2—Fluorouracil—pancreatic cancer	0.0343	0.192	CbGbCtD
Pentoxifylline—Caffeine—PIK3CD—pancreatic cancer	0.00763	0.361	CrCbGaD
Pentoxifylline—Caffeine—PIK3CB—pancreatic cancer	0.00763	0.361	CrCbGaD
Pentoxifylline—Caffeine—PIK3CA—pancreatic cancer	0.0059	0.279	CrCbGaD
Pentoxifylline—Dyspepsia—Irinotecan—pancreatic cancer	0.000648	0.0015	CcSEcCtD
Pentoxifylline—Immune system disorder—Docetaxel—pancreatic cancer	0.000647	0.00149	CcSEcCtD
Pentoxifylline—Headache—Erlotinib—pancreatic cancer	0.000647	0.00149	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000642	0.00148	CcSEcCtD
Pentoxifylline—Asthenia—Sunitinib—pancreatic cancer	0.000641	0.00148	CcSEcCtD
Pentoxifylline—Decreased appetite—Irinotecan—pancreatic cancer	0.00064	0.00148	CcSEcCtD
Pentoxifylline—Arrhythmia—Docetaxel—pancreatic cancer	0.00064	0.00148	CcSEcCtD
Pentoxifylline—Dyspnoea—Gemcitabine—pancreatic cancer	0.000639	0.00148	CcSEcCtD
Pentoxifylline—Insomnia—Fluorouracil—pancreatic cancer	0.000637	0.00147	CcSEcCtD
Pentoxifylline—Somnolence—Gemcitabine—pancreatic cancer	0.000637	0.00147	CcSEcCtD
Pentoxifylline—Pruritus—Sunitinib—pancreatic cancer	0.000632	0.00146	CcSEcCtD
Pentoxifylline—Constipation—Irinotecan—pancreatic cancer	0.000629	0.00145	CcSEcCtD
Pentoxifylline—Dyspnoea—Fluorouracil—pancreatic cancer	0.000628	0.00145	CcSEcCtD
Pentoxifylline—Somnolence—Fluorouracil—pancreatic cancer	0.000627	0.00145	CcSEcCtD
Pentoxifylline—Erythema—Docetaxel—pancreatic cancer	0.000623	0.00144	CcSEcCtD
Pentoxifylline—Decreased appetite—Gemcitabine—pancreatic cancer	0.000623	0.00144	CcSEcCtD
Pentoxifylline—Dyspepsia—Fluorouracil—pancreatic cancer	0.00062	0.00143	CcSEcCtD
Pentoxifylline—Nausea—Tamoxifen—pancreatic cancer	0.00062	0.00143	CcSEcCtD
Pentoxifylline—Constipation—Gemcitabine—pancreatic cancer	0.000613	0.00142	CcSEcCtD
Pentoxifylline—Nausea—Erlotinib—pancreatic cancer	0.000613	0.00142	CcSEcCtD
Pentoxifylline—Decreased appetite—Fluorouracil—pancreatic cancer	0.000613	0.00142	CcSEcCtD
Pentoxifylline—Diarrhoea—Sunitinib—pancreatic cancer	0.000611	0.00141	CcSEcCtD
Pentoxifylline—Dysgeusia—Docetaxel—pancreatic cancer	0.00061	0.00141	CcSEcCtD
Pentoxifylline—Abdominal distension—Epirubicin—pancreatic cancer	0.000607	0.0014	CcSEcCtD
Pentoxifylline—Feeling abnormal—Irinotecan—pancreatic cancer	0.000606	0.0014	CcSEcCtD
Pentoxifylline—Back pain—Docetaxel—pancreatic cancer	0.000603	0.00139	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000602	0.00139	CcSEcCtD
Pentoxifylline—Muscle spasms—Docetaxel—pancreatic cancer	0.000599	0.00138	CcSEcCtD
Pentoxifylline—Dizziness—Sunitinib—pancreatic cancer	0.000591	0.00136	CcSEcCtD
Pentoxifylline—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000591	0.00136	CcSEcCtD
Pentoxifylline—Angina pectoris—Epirubicin—pancreatic cancer	0.000588	0.00136	CcSEcCtD
Pentoxifylline—Abdominal pain—Irinotecan—pancreatic cancer	0.000582	0.00134	CcSEcCtD
Pentoxifylline—Body temperature increased—Irinotecan—pancreatic cancer	0.000582	0.00134	CcSEcCtD
Pentoxifylline—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000581	0.00134	CcSEcCtD
Pentoxifylline—Anaemia—Docetaxel—pancreatic cancer	0.000576	0.00133	CcSEcCtD
Pentoxifylline—Pancytopenia—Epirubicin—pancreatic cancer	0.000573	0.00132	CcSEcCtD
Pentoxifylline—Vomiting—Sunitinib—pancreatic cancer	0.000568	0.00131	CcSEcCtD
Pentoxifylline—Body temperature increased—Gemcitabine—pancreatic cancer	0.000567	0.00131	CcSEcCtD
Pentoxifylline—Rash—Sunitinib—pancreatic cancer	0.000563	0.0013	CcSEcCtD
Pentoxifylline—Dermatitis—Sunitinib—pancreatic cancer	0.000563	0.0013	CcSEcCtD
Pentoxifylline—Abdominal distension—Doxorubicin—pancreatic cancer	0.000562	0.0013	CcSEcCtD
Pentoxifylline—Urticaria—Fluorouracil—pancreatic cancer	0.00056	0.00129	CcSEcCtD
Pentoxifylline—Headache—Sunitinib—pancreatic cancer	0.00056	0.00129	CcSEcCtD
Pentoxifylline—Leukopenia—Docetaxel—pancreatic cancer	0.000558	0.00129	CcSEcCtD
Pentoxifylline—Body temperature increased—Fluorouracil—pancreatic cancer	0.000557	0.00129	CcSEcCtD
Pentoxifylline—Palpitations—Docetaxel—pancreatic cancer	0.000551	0.00127	CcSEcCtD
Pentoxifylline—Angina pectoris—Doxorubicin—pancreatic cancer	0.000544	0.00126	CcSEcCtD
Pentoxifylline—Hypersensitivity—Irinotecan—pancreatic cancer	0.000542	0.00125	CcSEcCtD
Pentoxifylline—Convulsion—Docetaxel—pancreatic cancer	0.00054	0.00125	CcSEcCtD
Pentoxifylline—Hypertension—Docetaxel—pancreatic cancer	0.000538	0.00124	CcSEcCtD
Pentoxifylline—Infestation—Epirubicin—pancreatic cancer	0.000538	0.00124	CcSEcCtD
Pentoxifylline—Drowsiness—Epirubicin—pancreatic cancer	0.000538	0.00124	CcSEcCtD
Pentoxifylline—Infestation NOS—Epirubicin—pancreatic cancer	0.000538	0.00124	CcSEcCtD
Pentoxifylline—Myalgia—Docetaxel—pancreatic cancer	0.000531	0.00123	CcSEcCtD
Pentoxifylline—Chest pain—Docetaxel—pancreatic cancer	0.000531	0.00123	CcSEcCtD
Pentoxifylline—Nausea—Sunitinib—pancreatic cancer	0.000531	0.00123	CcSEcCtD
Pentoxifylline—Pancytopenia—Doxorubicin—pancreatic cancer	0.00053	0.00122	CcSEcCtD
Pentoxifylline—Asthenia—Irinotecan—pancreatic cancer	0.000528	0.00122	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000527	0.00122	CcSEcCtD
Pentoxifylline—Jaundice—Epirubicin—pancreatic cancer	0.000524	0.00121	CcSEcCtD
Pentoxifylline—Conjunctivitis—Epirubicin—pancreatic cancer	0.000523	0.00121	CcSEcCtD
Pentoxifylline—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000519	0.0012	CcSEcCtD
Pentoxifylline—Dry mouth—Docetaxel—pancreatic cancer	0.000519	0.0012	CcSEcCtD
Pentoxifylline—Sweating—Epirubicin—pancreatic cancer	0.000516	0.00119	CcSEcCtD
Pentoxifylline—Asthenia—Gemcitabine—pancreatic cancer	0.000514	0.00119	CcSEcCtD
Pentoxifylline—Confusional state—Docetaxel—pancreatic cancer	0.000513	0.00118	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000509	0.00118	CcSEcCtD
Pentoxifylline—Oedema—Docetaxel—pancreatic cancer	0.000509	0.00117	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000509	0.00117	CcSEcCtD
Pentoxifylline—Epistaxis—Epirubicin—pancreatic cancer	0.000507	0.00117	CcSEcCtD
Pentoxifylline—Pruritus—Gemcitabine—pancreatic cancer	0.000507	0.00117	CcSEcCtD
Pentoxifylline—Infection—Docetaxel—pancreatic cancer	0.000505	0.00117	CcSEcCtD
Pentoxifylline—Diarrhoea—Irinotecan—pancreatic cancer	0.000504	0.00116	CcSEcCtD
Pentoxifylline—Shock—Docetaxel—pancreatic cancer	0.0005	0.00116	CcSEcCtD
Pentoxifylline—Pruritus—Fluorouracil—pancreatic cancer	0.000499	0.00115	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000498	0.00115	CcSEcCtD
Pentoxifylline—Infestation NOS—Doxorubicin—pancreatic cancer	0.000498	0.00115	CcSEcCtD
Pentoxifylline—Drowsiness—Doxorubicin—pancreatic cancer	0.000498	0.00115	CcSEcCtD
Pentoxifylline—Infestation—Doxorubicin—pancreatic cancer	0.000498	0.00115	CcSEcCtD
Pentoxifylline—Tachycardia—Docetaxel—pancreatic cancer	0.000496	0.00115	CcSEcCtD
Pentoxifylline—Skin disorder—Docetaxel—pancreatic cancer	0.000494	0.00114	CcSEcCtD
Pentoxifylline—Diarrhoea—Gemcitabine—pancreatic cancer	0.00049	0.00113	CcSEcCtD
Pentoxifylline—Dizziness—Irinotecan—pancreatic cancer	0.000487	0.00112	CcSEcCtD
Pentoxifylline—Haemoglobin—Epirubicin—pancreatic cancer	0.000485	0.00112	CcSEcCtD
Pentoxifylline—Jaundice—Doxorubicin—pancreatic cancer	0.000485	0.00112	CcSEcCtD
Pentoxifylline—Anorexia—Docetaxel—pancreatic cancer	0.000485	0.00112	CcSEcCtD
Pentoxifylline—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000484	0.00112	CcSEcCtD
Pentoxifylline—Hepatitis—Epirubicin—pancreatic cancer	0.000483	0.00112	CcSEcCtD
Pentoxifylline—Haemorrhage—Epirubicin—pancreatic cancer	0.000483	0.00112	CcSEcCtD
Pentoxifylline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000482	0.00111	CcSEcCtD
Pentoxifylline—Sweating—Doxorubicin—pancreatic cancer	0.000477	0.0011	CcSEcCtD
Pentoxifylline—Hypotension—Docetaxel—pancreatic cancer	0.000475	0.0011	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000471	0.00109	CcSEcCtD
Pentoxifylline—Epistaxis—Doxorubicin—pancreatic cancer	0.00047	0.00108	CcSEcCtD
Pentoxifylline—Vomiting—Irinotecan—pancreatic cancer	0.000468	0.00108	CcSEcCtD
Pentoxifylline—Dizziness—Fluorouracil—pancreatic cancer	0.000466	0.00108	CcSEcCtD
Pentoxifylline—Rash—Irinotecan—pancreatic cancer	0.000464	0.00107	CcSEcCtD
Pentoxifylline—Dermatitis—Irinotecan—pancreatic cancer	0.000464	0.00107	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000463	0.00107	CcSEcCtD
Pentoxifylline—Headache—Irinotecan—pancreatic cancer	0.000461	0.00106	CcSEcCtD
Pentoxifylline—Insomnia—Docetaxel—pancreatic cancer	0.00046	0.00106	CcSEcCtD
Pentoxifylline—Vomiting—Gemcitabine—pancreatic cancer	0.000456	0.00105	CcSEcCtD
Pentoxifylline—Dyspnoea—Docetaxel—pancreatic cancer	0.000454	0.00105	CcSEcCtD
Pentoxifylline—Somnolence—Docetaxel—pancreatic cancer	0.000452	0.00104	CcSEcCtD
Pentoxifylline—Rash—Gemcitabine—pancreatic cancer	0.000452	0.00104	CcSEcCtD
Pentoxifylline—Dermatitis—Gemcitabine—pancreatic cancer	0.000452	0.00104	CcSEcCtD
Pentoxifylline—Haemoglobin—Doxorubicin—pancreatic cancer	0.000449	0.00104	CcSEcCtD
Pentoxifylline—Headache—Gemcitabine—pancreatic cancer	0.000449	0.00104	CcSEcCtD
Pentoxifylline—Flushing—Epirubicin—pancreatic cancer	0.000448	0.00104	CcSEcCtD
Pentoxifylline—Vomiting—Fluorouracil—pancreatic cancer	0.000448	0.00104	CcSEcCtD
Pentoxifylline—Dyspepsia—Docetaxel—pancreatic cancer	0.000448	0.00103	CcSEcCtD
Pentoxifylline—Haemorrhage—Doxorubicin—pancreatic cancer	0.000447	0.00103	CcSEcCtD
Pentoxifylline—Hepatitis—Doxorubicin—pancreatic cancer	0.000447	0.00103	CcSEcCtD
Pentoxifylline—Rash—Fluorouracil—pancreatic cancer	0.000444	0.00103	CcSEcCtD
Pentoxifylline—Dermatitis—Fluorouracil—pancreatic cancer	0.000444	0.00103	CcSEcCtD
Pentoxifylline—Decreased appetite—Docetaxel—pancreatic cancer	0.000442	0.00102	CcSEcCtD
Pentoxifylline—Headache—Fluorouracil—pancreatic cancer	0.000442	0.00102	CcSEcCtD
Pentoxifylline—Nausea—Irinotecan—pancreatic cancer	0.000437	0.00101	CcSEcCtD
Pentoxifylline—Immune system disorder—Epirubicin—pancreatic cancer	0.000436	0.00101	CcSEcCtD
Pentoxifylline—Constipation—Docetaxel—pancreatic cancer	0.000435	0.001	CcSEcCtD
Pentoxifylline—Arrhythmia—Epirubicin—pancreatic cancer	0.000431	0.000997	CcSEcCtD
Pentoxifylline—Nausea—Gemcitabine—pancreatic cancer	0.000426	0.000983	CcSEcCtD
Pentoxifylline—Erythema—Epirubicin—pancreatic cancer	0.00042	0.000971	CcSEcCtD
Pentoxifylline—Feeling abnormal—Docetaxel—pancreatic cancer	0.000419	0.000968	CcSEcCtD
Pentoxifylline—Nausea—Fluorouracil—pancreatic cancer	0.000419	0.000967	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000416	0.000961	CcSEcCtD
Pentoxifylline—Flushing—Doxorubicin—pancreatic cancer	0.000415	0.000958	CcSEcCtD
Pentoxifylline—Flatulence—Epirubicin—pancreatic cancer	0.000414	0.000957	CcSEcCtD
Pentoxifylline—Tension—Epirubicin—pancreatic cancer	0.000413	0.000953	CcSEcCtD
Pentoxifylline—Dysgeusia—Epirubicin—pancreatic cancer	0.000412	0.000951	CcSEcCtD
Pentoxifylline—Nervousness—Epirubicin—pancreatic cancer	0.000408	0.000943	CcSEcCtD
Pentoxifylline—Back pain—Epirubicin—pancreatic cancer	0.000407	0.000939	CcSEcCtD
Pentoxifylline—Muscle spasms—Epirubicin—pancreatic cancer	0.000404	0.000934	CcSEcCtD
Pentoxifylline—Immune system disorder—Doxorubicin—pancreatic cancer	0.000404	0.000932	CcSEcCtD
Pentoxifylline—Abdominal pain—Docetaxel—pancreatic cancer	0.000402	0.000929	CcSEcCtD
Pentoxifylline—Body temperature increased—Docetaxel—pancreatic cancer	0.000402	0.000929	CcSEcCtD
Pentoxifylline—Arrhythmia—Doxorubicin—pancreatic cancer	0.000399	0.000922	CcSEcCtD
Pentoxifylline—Vision blurred—Epirubicin—pancreatic cancer	0.000396	0.000915	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00039	0.000901	CcSEcCtD
Pentoxifylline—Erythema—Doxorubicin—pancreatic cancer	0.000389	0.000899	CcSEcCtD
Pentoxifylline—Anaemia—Epirubicin—pancreatic cancer	0.000389	0.000898	CcSEcCtD
Pentoxifylline—Agitation—Epirubicin—pancreatic cancer	0.000386	0.000892	CcSEcCtD
Pentoxifylline—Flatulence—Doxorubicin—pancreatic cancer	0.000383	0.000885	CcSEcCtD
Pentoxifylline—Tension—Doxorubicin—pancreatic cancer	0.000382	0.000882	CcSEcCtD
Pentoxifylline—Dysgeusia—Doxorubicin—pancreatic cancer	0.000381	0.00088	CcSEcCtD
Pentoxifylline—Malaise—Epirubicin—pancreatic cancer	0.000379	0.000876	CcSEcCtD
Pentoxifylline—Nervousness—Doxorubicin—pancreatic cancer	0.000378	0.000873	CcSEcCtD
Pentoxifylline—Leukopenia—Epirubicin—pancreatic cancer	0.000376	0.000869	CcSEcCtD
Pentoxifylline—Back pain—Doxorubicin—pancreatic cancer	0.000376	0.000869	CcSEcCtD
Pentoxifylline—Hypersensitivity—Docetaxel—pancreatic cancer	0.000375	0.000866	CcSEcCtD
Pentoxifylline—Muscle spasms—Doxorubicin—pancreatic cancer	0.000374	0.000864	CcSEcCtD
Pentoxifylline—Palpitations—Epirubicin—pancreatic cancer	0.000372	0.000858	CcSEcCtD
Pentoxifylline—Vision blurred—Doxorubicin—pancreatic cancer	0.000367	0.000847	CcSEcCtD
Pentoxifylline—Asthenia—Docetaxel—pancreatic cancer	0.000365	0.000843	CcSEcCtD
Pentoxifylline—Convulsion—Epirubicin—pancreatic cancer	0.000364	0.000841	CcSEcCtD
Pentoxifylline—Hypertension—Epirubicin—pancreatic cancer	0.000363	0.000838	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000361	0.000834	CcSEcCtD
Pentoxifylline—Pruritus—Docetaxel—pancreatic cancer	0.00036	0.000831	CcSEcCtD
Pentoxifylline—Anaemia—Doxorubicin—pancreatic cancer	0.00036	0.00083	CcSEcCtD
Pentoxifylline—Chest pain—Epirubicin—pancreatic cancer	0.000358	0.000827	CcSEcCtD
Pentoxifylline—Myalgia—Epirubicin—pancreatic cancer	0.000358	0.000827	CcSEcCtD
Pentoxifylline—Agitation—Doxorubicin—pancreatic cancer	0.000357	0.000826	CcSEcCtD
Pentoxifylline—Anxiety—Epirubicin—pancreatic cancer	0.000357	0.000824	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000355	0.000821	CcSEcCtD
Pentoxifylline—Discomfort—Epirubicin—pancreatic cancer	0.000354	0.000817	CcSEcCtD
Pentoxifylline—Malaise—Doxorubicin—pancreatic cancer	0.000351	0.00081	CcSEcCtD
Pentoxifylline—Dry mouth—Epirubicin—pancreatic cancer	0.00035	0.000809	CcSEcCtD
Pentoxifylline—Leukopenia—Doxorubicin—pancreatic cancer	0.000348	0.000804	CcSEcCtD
Pentoxifylline—Diarrhoea—Docetaxel—pancreatic cancer	0.000348	0.000804	CcSEcCtD
Pentoxifylline—Confusional state—Epirubicin—pancreatic cancer	0.000346	0.000799	CcSEcCtD
Pentoxifylline—Palpitations—Doxorubicin—pancreatic cancer	0.000344	0.000794	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000343	0.000793	CcSEcCtD
Pentoxifylline—Oedema—Epirubicin—pancreatic cancer	0.000343	0.000793	CcSEcCtD
Pentoxifylline—Infection—Epirubicin—pancreatic cancer	0.000341	0.000787	CcSEcCtD
Pentoxifylline—Shock—Epirubicin—pancreatic cancer	0.000338	0.00078	CcSEcCtD
Pentoxifylline—Convulsion—Doxorubicin—pancreatic cancer	0.000337	0.000778	CcSEcCtD
Pentoxifylline—Dizziness—Docetaxel—pancreatic cancer	0.000336	0.000777	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000336	0.000776	CcSEcCtD
Pentoxifylline—Hypertension—Doxorubicin—pancreatic cancer	0.000336	0.000776	CcSEcCtD
Pentoxifylline—Tachycardia—Epirubicin—pancreatic cancer	0.000335	0.000773	CcSEcCtD
Pentoxifylline—Skin disorder—Epirubicin—pancreatic cancer	0.000333	0.00077	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000332	0.000766	CcSEcCtD
Pentoxifylline—Myalgia—Doxorubicin—pancreatic cancer	0.000331	0.000765	CcSEcCtD
Pentoxifylline—Chest pain—Doxorubicin—pancreatic cancer	0.000331	0.000765	CcSEcCtD
Pentoxifylline—Anxiety—Doxorubicin—pancreatic cancer	0.00033	0.000762	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000329	0.00076	CcSEcCtD
Pentoxifylline—Discomfort—Doxorubicin—pancreatic cancer	0.000327	0.000756	CcSEcCtD
Pentoxifylline—Anorexia—Epirubicin—pancreatic cancer	0.000327	0.000755	CcSEcCtD
Pentoxifylline—Dry mouth—Doxorubicin—pancreatic cancer	0.000324	0.000748	CcSEcCtD
Pentoxifylline—Vomiting—Docetaxel—pancreatic cancer	0.000323	0.000747	CcSEcCtD
Pentoxifylline—Rash—Docetaxel—pancreatic cancer	0.000321	0.000741	CcSEcCtD
Pentoxifylline—Hypotension—Epirubicin—pancreatic cancer	0.000321	0.000741	CcSEcCtD
Pentoxifylline—Dermatitis—Docetaxel—pancreatic cancer	0.00032	0.00074	CcSEcCtD
Pentoxifylline—Confusional state—Doxorubicin—pancreatic cancer	0.00032	0.000739	CcSEcCtD
Pentoxifylline—Headache—Docetaxel—pancreatic cancer	0.000319	0.000736	CcSEcCtD
Pentoxifylline—Oedema—Doxorubicin—pancreatic cancer	0.000317	0.000733	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000317	0.000733	CcSEcCtD
Pentoxifylline—Infection—Doxorubicin—pancreatic cancer	0.000315	0.000729	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000313	0.000722	CcSEcCtD
Pentoxifylline—Shock—Doxorubicin—pancreatic cancer	0.000312	0.000721	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000311	0.000718	CcSEcCtD
Pentoxifylline—Insomnia—Epirubicin—pancreatic cancer	0.00031	0.000717	CcSEcCtD
Pentoxifylline—Tachycardia—Doxorubicin—pancreatic cancer	0.00031	0.000716	CcSEcCtD
Pentoxifylline—Skin disorder—Doxorubicin—pancreatic cancer	0.000308	0.000712	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000307	0.000709	CcSEcCtD
Pentoxifylline—Dyspnoea—Epirubicin—pancreatic cancer	0.000306	0.000707	CcSEcCtD
Pentoxifylline—Somnolence—Epirubicin—pancreatic cancer	0.000305	0.000705	CcSEcCtD
Pentoxifylline—Anorexia—Doxorubicin—pancreatic cancer	0.000303	0.000699	CcSEcCtD
Pentoxifylline—Nausea—Docetaxel—pancreatic cancer	0.000302	0.000698	CcSEcCtD
Pentoxifylline—Dyspepsia—Epirubicin—pancreatic cancer	0.000302	0.000698	CcSEcCtD
Pentoxifylline—Decreased appetite—Epirubicin—pancreatic cancer	0.000298	0.000689	CcSEcCtD
Pentoxifylline—Hypotension—Doxorubicin—pancreatic cancer	0.000297	0.000685	CcSEcCtD
Pentoxifylline—Constipation—Epirubicin—pancreatic cancer	0.000293	0.000678	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000289	0.000668	CcSEcCtD
Pentoxifylline—Insomnia—Doxorubicin—pancreatic cancer	0.000287	0.000663	CcSEcCtD
Pentoxifylline—Dyspnoea—Doxorubicin—pancreatic cancer	0.000283	0.000654	CcSEcCtD
Pentoxifylline—Feeling abnormal—Epirubicin—pancreatic cancer	0.000283	0.000653	CcSEcCtD
Pentoxifylline—Somnolence—Doxorubicin—pancreatic cancer	0.000282	0.000652	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000281	0.000648	CcSEcCtD
Pentoxifylline—Dyspepsia—Doxorubicin—pancreatic cancer	0.000279	0.000645	CcSEcCtD
Pentoxifylline—Decreased appetite—Doxorubicin—pancreatic cancer	0.000276	0.000637	CcSEcCtD
Pentoxifylline—Urticaria—Epirubicin—pancreatic cancer	0.000273	0.00063	CcSEcCtD
Pentoxifylline—Constipation—Doxorubicin—pancreatic cancer	0.000271	0.000627	CcSEcCtD
Pentoxifylline—Body temperature increased—Epirubicin—pancreatic cancer	0.000271	0.000627	CcSEcCtD
Pentoxifylline—Abdominal pain—Epirubicin—pancreatic cancer	0.000271	0.000627	CcSEcCtD
Pentoxifylline—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000262	0.000604	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.00026	0.0006	CcSEcCtD
Pentoxifylline—Hypersensitivity—Epirubicin—pancreatic cancer	0.000253	0.000584	CcSEcCtD
Pentoxifylline—Urticaria—Doxorubicin—pancreatic cancer	0.000252	0.000583	CcSEcCtD
Pentoxifylline—Abdominal pain—Doxorubicin—pancreatic cancer	0.000251	0.00058	CcSEcCtD
Pentoxifylline—Body temperature increased—Doxorubicin—pancreatic cancer	0.000251	0.00058	CcSEcCtD
Pentoxifylline—Asthenia—Epirubicin—pancreatic cancer	0.000246	0.000569	CcSEcCtD
Pentoxifylline—Pruritus—Epirubicin—pancreatic cancer	0.000243	0.000561	CcSEcCtD
Pentoxifylline—Diarrhoea—Epirubicin—pancreatic cancer	0.000235	0.000542	CcSEcCtD
Pentoxifylline—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000234	0.00054	CcSEcCtD
Pentoxifylline—Asthenia—Doxorubicin—pancreatic cancer	0.000228	0.000526	CcSEcCtD
Pentoxifylline—Dizziness—Epirubicin—pancreatic cancer	0.000227	0.000524	CcSEcCtD
Pentoxifylline—Pruritus—Doxorubicin—pancreatic cancer	0.000225	0.000519	CcSEcCtD
Pentoxifylline—Vomiting—Epirubicin—pancreatic cancer	0.000218	0.000504	CcSEcCtD
Pentoxifylline—Diarrhoea—Doxorubicin—pancreatic cancer	0.000217	0.000502	CcSEcCtD
Pentoxifylline—Rash—Epirubicin—pancreatic cancer	0.000216	0.0005	CcSEcCtD
Pentoxifylline—Dermatitis—Epirubicin—pancreatic cancer	0.000216	0.000499	CcSEcCtD
Pentoxifylline—Headache—Epirubicin—pancreatic cancer	0.000215	0.000496	CcSEcCtD
Pentoxifylline—Dizziness—Doxorubicin—pancreatic cancer	0.00021	0.000485	CcSEcCtD
Pentoxifylline—Nausea—Epirubicin—pancreatic cancer	0.000204	0.000471	CcSEcCtD
Pentoxifylline—Vomiting—Doxorubicin—pancreatic cancer	0.000202	0.000466	CcSEcCtD
Pentoxifylline—Rash—Doxorubicin—pancreatic cancer	0.0002	0.000462	CcSEcCtD
Pentoxifylline—Dermatitis—Doxorubicin—pancreatic cancer	0.0002	0.000462	CcSEcCtD
Pentoxifylline—Headache—Doxorubicin—pancreatic cancer	0.000199	0.000459	CcSEcCtD
Pentoxifylline—Nausea—Doxorubicin—pancreatic cancer	0.000189	0.000436	CcSEcCtD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CD—pancreatic cancer	8.69e-05	0.000237	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCL8—pancreatic cancer	8.67e-05	0.000236	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCL8—pancreatic cancer	8.67e-05	0.000236	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SST—pancreatic cancer	8.63e-05	0.000235	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HES1—pancreatic cancer	8.55e-05	0.000233	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CG—pancreatic cancer	8.51e-05	0.000232	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.44e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JAG1—pancreatic cancer	8.44e-05	0.00023	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH3—pancreatic cancer	8.41e-05	0.000229	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.34e-05	0.000228	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TERT—pancreatic cancer	8.25e-05	0.000225	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SMAD4—pancreatic cancer	8.2e-05	0.000224	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CB—pancreatic cancer	8.19e-05	0.000223	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL8—pancreatic cancer	8.11e-05	0.000221	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKT1—pancreatic cancer	8.11e-05	0.000221	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SMAD4—pancreatic cancer	8.1e-05	0.000221	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL8—pancreatic cancer	8.02e-05	0.000219	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HES1—pancreatic cancer	8.01e-05	0.000218	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CNR1—pancreatic cancer	7.96e-05	0.000217	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HES1—pancreatic cancer	7.91e-05	0.000216	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HIF1A—pancreatic cancer	7.89e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TSC2—pancreatic cancer	7.87e-05	0.000215	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL8—pancreatic cancer	7.87e-05	0.000215	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CG—pancreatic cancer	7.73e-05	0.000211	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—pancreatic cancer	7.7e-05	0.00021	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—GCG—pancreatic cancer	7.69e-05	0.00021	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—PIK3CA—pancreatic cancer	7.68e-05	0.000209	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.67e-05	0.000209	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CB—pancreatic cancer	7.58e-05	0.000207	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KDR—pancreatic cancer	7.55e-05	0.000206	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TERT—pancreatic cancer	7.49e-05	0.000204	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CD—pancreatic cancer	7.48e-05	0.000204	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL8—pancreatic cancer	7.37e-05	0.000201	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AGTR1—pancreatic cancer	7.33e-05	0.0002	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL8—pancreatic cancer	7.28e-05	0.000199	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STK11—pancreatic cancer	7.23e-05	0.000197	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NFKBIA—pancreatic cancer	7.18e-05	0.000196	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HIF1A—pancreatic cancer	7.17e-05	0.000195	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TSC2—pancreatic cancer	7.15e-05	0.000195	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NOTCH1—pancreatic cancer	7.11e-05	0.000194	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TERT—pancreatic cancer	7.02e-05	0.000191	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—pancreatic cancer	6.99e-05	0.000191	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CG—pancreatic cancer	6.95e-05	0.00019	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—NRAS—pancreatic cancer	6.95e-05	0.00019	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TERT—pancreatic cancer	6.93e-05	0.000189	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGF—pancreatic cancer	6.87e-05	0.000187	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KDR—pancreatic cancer	6.85e-05	0.000187	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	6.79e-05	0.000185	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HIF1A—pancreatic cancer	6.71e-05	0.000183	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TSC2—pancreatic cancer	6.69e-05	0.000183	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HIF1A—pancreatic cancer	6.63e-05	0.000181	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TSC2—pancreatic cancer	6.61e-05	0.00018	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—pancreatic cancer	6.55e-05	0.000179	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	6.52e-05	0.000178	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NFKBIA—pancreatic cancer	6.52e-05	0.000178	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—pancreatic cancer	6.47e-05	0.000176	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NOTCH1—pancreatic cancer	6.46e-05	0.000176	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KDR—pancreatic cancer	6.42e-05	0.000175	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KDR—pancreatic cancer	6.34e-05	0.000173	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—pancreatic cancer	6.33e-05	0.000173	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SMAD4—pancreatic cancer	6.33e-05	0.000173	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CG—pancreatic cancer	6.31e-05	0.000172	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—NRAS—pancreatic cancer	6.31e-05	0.000172	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—pancreatic cancer	6.27e-05	0.000171	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	6.26e-05	0.000171	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGF—pancreatic cancer	6.24e-05	0.00017	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HES1—pancreatic cancer	6.18e-05	0.000169	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CD—pancreatic cancer	6.11e-05	0.000167	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NFKBIA—pancreatic cancer	6.1e-05	0.000166	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	6.05e-05	0.000165	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NOTCH1—pancreatic cancer	6.04e-05	0.000165	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NFKBIA—pancreatic cancer	6.03e-05	0.000164	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PRSS1—pancreatic cancer	6.03e-05	0.000164	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—KRAS—pancreatic cancer	5.98e-05	0.000163	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NOTCH1—pancreatic cancer	5.97e-05	0.000163	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	5.92e-05	0.000161	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CG—pancreatic cancer	5.91e-05	0.000161	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—NRAS—pancreatic cancer	5.91e-05	0.000161	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGF—pancreatic cancer	5.84e-05	0.000159	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CG—pancreatic cancer	5.84e-05	0.000159	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—NRAS—pancreatic cancer	5.84e-05	0.000159	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGF—pancreatic cancer	5.77e-05	0.000157	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—pancreatic cancer	5.75e-05	0.000157	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL8—pancreatic cancer	5.69e-05	0.000155	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CD—pancreatic cancer	5.55e-05	0.000151	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	5.5e-05	0.00015	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.5e-05	0.00015	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—KRAS—pancreatic cancer	5.43e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TERT—pancreatic cancer	5.42e-05	0.000148	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—pancreatic cancer	5.39e-05	0.000147	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CB—pancreatic cancer	5.33e-05	0.000145	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—pancreatic cancer	5.32e-05	0.000145	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ARG2—pancreatic cancer	5.23e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CD—pancreatic cancer	5.2e-05	0.000142	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HIF1A—pancreatic cancer	5.18e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSC2—pancreatic cancer	5.17e-05	0.000141	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.15e-05	0.00014	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CD—pancreatic cancer	5.13e-05	0.00014	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL8—pancreatic cancer	5.12e-05	0.00014	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—KRAS—pancreatic cancer	5.09e-05	0.000139	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.09e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—HRAS—pancreatic cancer	5.09e-05	0.000139	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—pancreatic cancer	5.06e-05	0.000138	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—KRAS—pancreatic cancer	5.03e-05	0.000137	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—PIK3CA—pancreatic cancer	4.99e-05	0.000136	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—pancreatic cancer	4.95e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—pancreatic cancer	4.95e-05	0.000135	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—pancreatic cancer	4.9e-05	0.000134	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CB—pancreatic cancer	4.84e-05	0.000132	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCND1—pancreatic cancer	4.77e-05	0.00013	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CTNNB1—pancreatic cancer	4.72e-05	0.000129	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NFKBIA—pancreatic cancer	4.71e-05	0.000129	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.67e-05	0.000127	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NOTCH1—pancreatic cancer	4.67e-05	0.000127	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL8—pancreatic cancer	4.65e-05	0.000127	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—pancreatic cancer	4.63e-05	0.000126	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—PIK3CA—pancreatic cancer	4.62e-05	0.000126	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—HRAS—pancreatic cancer	4.62e-05	0.000126	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PTEN—pancreatic cancer	4.6e-05	0.000126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMP—pancreatic cancer	4.57e-05	0.000125	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CG—pancreatic cancer	4.56e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—NRAS—pancreatic cancer	4.56e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CB—pancreatic cancer	4.53e-05	0.000124	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGF—pancreatic cancer	4.51e-05	0.000123	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—pancreatic cancer	4.49e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—pancreatic cancer	4.49e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CB—pancreatic cancer	4.48e-05	0.000122	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—pancreatic cancer	4.45e-05	0.000121	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL8—pancreatic cancer	4.35e-05	0.000119	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCND1—pancreatic cancer	4.33e-05	0.000118	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—HRAS—pancreatic cancer	4.32e-05	0.000118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL8—pancreatic cancer	4.3e-05	0.000117	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CTNNB1—pancreatic cancer	4.29e-05	0.000117	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—HRAS—pancreatic cancer	4.27e-05	0.000117	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SRC—pancreatic cancer	4.27e-05	0.000116	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—pancreatic cancer	4.2e-05	0.000115	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—pancreatic cancer	4.2e-05	0.000115	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PTEN—pancreatic cancer	4.18e-05	0.000114	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—pancreatic cancer	4.17e-05	0.000114	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—pancreatic cancer	4.16e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—pancreatic cancer	4.16e-05	0.000113	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—pancreatic cancer	4.15e-05	0.000113	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—STAT3—pancreatic cancer	4.12e-05	0.000112	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—pancreatic cancer	4.12e-05	0.000112	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NRAS—pancreatic cancer	4.11e-05	0.000112	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—pancreatic cancer	4.08e-05	0.000111	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCND1—pancreatic cancer	4.06e-05	0.000111	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CTNNB1—pancreatic cancer	4.02e-05	0.00011	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CD—pancreatic cancer	4.01e-05	0.000109	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCND1—pancreatic cancer	4.01e-05	0.000109	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	3.97e-05	0.000108	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CTNNB1—pancreatic cancer	3.97e-05	0.000108	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—pancreatic cancer	3.94e-05	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—KRAS—pancreatic cancer	3.93e-05	0.000107	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PTEN—pancreatic cancer	3.91e-05	0.000107	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—pancreatic cancer	3.89e-05	0.000106	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SRC—pancreatic cancer	3.88e-05	0.000106	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PTEN—pancreatic cancer	3.87e-05	0.000105	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MYC—pancreatic cancer	3.83e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	3.82e-05	0.000104	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TGFB1—pancreatic cancer	3.82e-05	0.000104	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—pancreatic cancer	3.78e-05	0.000103	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—pancreatic cancer	3.77e-05	0.000103	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.77e-05	0.000103	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—pancreatic cancer	3.74e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—STAT3—pancreatic cancer	3.74e-05	0.000102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NRAS—pancreatic cancer	3.73e-05	0.000102	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GLP1R—pancreatic cancer	3.68e-05	0.0001	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SRC—pancreatic cancer	3.63e-05	9.9e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—DPYD—pancreatic cancer	3.62e-05	9.88e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	3.61e-05	9.84e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SRC—pancreatic cancer	3.59e-05	9.78e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	3.54e-05	9.64e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KRAS—pancreatic cancer	3.53e-05	9.64e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	3.5e-05	9.55e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	3.5e-05	9.54e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—pancreatic cancer	3.49e-05	9.53e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	3.49e-05	9.52e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MYC—pancreatic cancer	3.47e-05	9.47e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TGFB1—pancreatic cancer	3.47e-05	9.45e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—STAT3—pancreatic cancer	3.46e-05	9.43e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NRAS—pancreatic cancer	3.45e-05	9.41e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	3.44e-05	9.37e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.4e-05	9.28e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—pancreatic cancer	3.4e-05	9.26e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	3.36e-05	9.16e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	3.34e-05	9.1e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.28e-05	8.95e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MYC—pancreatic cancer	3.25e-05	8.87e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PIK3CA—pancreatic cancer	3.25e-05	8.86e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	3.25e-05	8.85e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	3.24e-05	8.85e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	3.22e-05	8.77e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MYC—pancreatic cancer	3.21e-05	8.76e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KRAS—pancreatic cancer	3.21e-05	8.75e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TGFB1—pancreatic cancer	3.21e-05	8.74e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	3.18e-05	8.68e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—pancreatic cancer	3.14e-05	8.57e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TP53—pancreatic cancer	3.14e-05	8.57e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	3.13e-05	8.54e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	3.1e-05	8.45e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	3.04e-05	8.29e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	3.02e-05	8.24e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	3.01e-05	8.2e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HRAS—pancreatic cancer	3e-05	8.19e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.99e-05	8.15e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KRAS—pancreatic cancer	2.97e-05	8.1e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PIK3CA—pancreatic cancer	2.95e-05	8.04e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	2.95e-05	8.04e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TP53—pancreatic cancer	2.85e-05	7.78e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	2.8e-05	7.64e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	2.76e-05	7.53e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	2.73e-05	7.44e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PIK3CA—pancreatic cancer	2.73e-05	7.44e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HRAS—pancreatic cancer	2.73e-05	7.44e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	2.7e-05	7.37e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	2.7e-05	7.35e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TP53—pancreatic cancer	2.67e-05	7.28e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CD44—pancreatic cancer	2.66e-05	7.26e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—pancreatic cancer	2.65e-05	7.23e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TP53—pancreatic cancer	2.64e-05	7.2e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.61e-05	7.11e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.58e-05	7.04e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	2.55e-05	6.97e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GCG—pancreatic cancer	2.55e-05	6.96e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HRAS—pancreatic cancer	2.52e-05	6.88e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	2.51e-05	6.85e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	2.51e-05	6.83e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	2.46e-05	6.7e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—pancreatic cancer	2.41e-05	6.57e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—STK11—pancreatic cancer	2.4e-05	6.54e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	2.32e-05	6.33e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	2.26e-05	6.15e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.25e-05	6.14e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—pancreatic cancer	2.23e-05	6.08e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.13e-05	5.81e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.06e-05	5.63e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	2.06e-05	5.62e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	1.97e-05	5.38e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	1.74e-05	4.75e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—pancreatic cancer	1.68e-05	4.58e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.59e-05	4.33e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	1.51e-05	4.13e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.46e-05	3.99e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.33e-05	3.63e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.16e-05	3.17e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.15e-05	3.14e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTEN—pancreatic cancer	1e-05	2.74e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	7.08e-06	1.93e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—pancreatic cancer	5.78e-06	1.58e-05	CbGpPWpGaD
